Age matters: study measures exact ciprofol dose for loss of consciousness
NCT ID NCT07148596
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at 125 patients of different ages to find out how much ciprofol (an anesthetic drug) they needed to lose consciousness. Researchers measured the dose and brain activity (bispectral index) during anesthesia induction. The goal is to help doctors tailor ciprofol doses more precisely for safer anesthesia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ciprofol
- What this could lead to
- If successful, this could help anesthesiologists give safer, more personalized doses of ciprofol based on a patient's age.
- What could go wrong
- This is a small, single-center observational study, not a large trial. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIPROFOL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Safer anesthesia for kids? study hunts for ideal ciprofol dose
- Morning or afternoon surgery? study tests if body clock alters anesthesia safety
- New drug cocktail aims to cut breathing risks during sedation in seniors
- New anesthetic may keep blood pressure steadier during surgery in older adults
- New sedative studied in patients with low protein levels